title: Abiraterone's efficacy confirmed; time to aim higher.
authors.affiliation: Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: madanr@mail.nih.gov.
authors.forename: Ravi
authors.initials: R
authors.lastname: Madan
authors.affiliation: Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: William L
authors.initials: WL
authors.lastname: Dahut
mesh_terms: D000736:Androstenes / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000401:mortality*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000401:mortality*
chemical_list: D000736:Androstenes; D018931:Antineoplastic Agents, Hormonal; C089740:abiraterone; D011241:Prednisone